First Quarter 2025 Results April 25, 2025 About this Presentation Unless otherwise stated, references to "Canadian Malartic", "Goldex", "LaRonde" and "Meadowbank" are to the Company's operations at the Canadian Malartic complex, the Goldex complex, the LaRonde complex and the Meadowbank complex, respectively. The Canadian Malartic complex consists of the mining, milling and processing operations at the Canadian Malartic mine and the mining operations at the Odyssey mine. The Goldex complex consists of the m ...

Investor Presentation Delivering therapy where it matters® March 2025 © RenovoRx, Inc. All rights reserved. NASDAQ | RNXT Cautionary Note Regarding Forward-Looking Statements This presentation and statements of the Company's management made in connection therewith contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding (i) the potential of RenovoCath® or TAMP ...

FIRST QUARTER 2025 EARNINGS RESULTS FORWARD-LOOKING STATEMENTS This presentation contains statements concerning the company's future results and performance that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including, but not limited to, with respect to: our second quarter 2025 outlook and expectations concerning earnings and Adjusted EBITDA for each of our businesses and expected key drivers; our full-year 2025 outlook for Real Estate, Energy & N ...

COLGATE-PALMOLIVE COMPANY 1Q 2025 EARNINGS PRESENTATION APRIL 25, 2025 April 2025 Notice for Investor Presentation Please review the following first quarter 2025 earnings presentation in conjunction with our first quarter 2025 earnings press release, our first quarter 2025 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Center section of our website at www.colgatepalmolive.com/in ...

First Quarter 2025 Results April 25, 2025 Our forward‐looking statements are subject to, among others, the following principal risks and uncertainties: general economic conditions and trends, either nationally or locally; conditions in the securities, credit and financial markets; changes in interest rates; changes in deposit flows, and in the demand for deposit, loan, and investment products and other financial services; changes in real estate values; changes in the quality or composition of our loan or in ...

Q1 2025 Earnings Earnings Presentation April 25, 2025 Disclaimer Forward-looking statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this presentation are forward-looking statements. Forward-looking s ...

First Quarter 2025 Financial Results April 25, 2025 1 Cautionary Note Regarding Forward-Looking Statements This presentation contains forward-looking statements, including, without limitation, those related to: strengthening demand in our CCS segment, demand environment and customer forecasts, our anticipated financial and/or operational results, guidance and outlook, including statements under the headings "Q2 2025 Guidance", "Q2 2025 Non-GAAP Tax Rate Estimate", "Q2 2025 End Market Revenue Outlook", "2025 ...

Welcome to R&D Day April 24, 2025 © 2025 Esperion Therapeutics, Inc. All rights reserved. Forward-looking Statements & Disclosures This investor presentation contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding marketing strategy and commercialization plans, current and planned operational expenses, future operations, commercial products, clinical development, plans for potential future product candidates, fin ...

Q1 2025 Quarterly Investor Presentation APRIL 24, 2025 Safe Harbor Statements contained in this presentation, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, regarding McGrath's (the "Company's") expectations, strategies, prospects, or targets are forward-looking statements. These forward-looking statements also can be identified by the use of forward-looking ...

BeFra Q1 2025 Earnings Results April 2025 Q1 2025 Highlights: BeFra Group Net revenue decreased 2.9%, driven by a decline in sales on Betterware Mexico of 9.8% and softer than expected, yet positive growth in Jafra Mexico of 1.1%, tempered by weak consumer spending amid macroeconomic uncertainty. Gross Margin declined 353 basis points mainly due to margin pressures in Betterware Mexico and Jafra Mexico from FX pressures resulting in higher costs with the Mexican Peso depreciating around 20% on a yearly basi ...